The Market Return To Pharmaceutical Product Approval: Market Valuation of Firms: An Event Study

 
9783639102833: The Market Return To Pharmaceutical Product Approval: Market Valuation of Firms: An Event Study

The stock and securities market should, ideally, react quickly (efficiently) in response to the public announcement of approval of new drug by the Food and Drug Administration (FDA) and the positive abnormal return may be expected for the sponsoring pharmaceutical company on and around the event date i.e. the day of the public announcement of the new drug approval for marketing. This study has found the mixed outcomes. Briefly, the findings are: (a) Existence of statistically significant positive abnormal returns (AR) for the day following the events. (b) The cumulative abnormal return (CAR) is statistically insignificant for the estimates of the pooled regressions and for some of the individual pharmaceutical companies. (c) No sign of information leakage ahead of the events. (d) Some individual pharmaceutical companies show the existence of statistically significant positive abnormal returns (AR) and the cumulative abnormal return (CAR) for event day and the day after (e.g. Novartis, Abbott, Schering Plough). These findings may play a significant role in the decision making process of mutually exclusive investments in the pharmaceutical products.

"synopsis" may belong to another edition of this title.

About the Author:

Imtiaz Ahmed, MA: Studied the Economics in the University of Texas at Arlington (UTA), Arlington, Texas, U.S.A. and also MA: Studied the Economics of Development at the Australian National University (ANU), Canberra, Australia.

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 66.00
US$ 42.99

Convert Currency

Shipping: US$ 5.14
From United Kingdom to U.S.A.

Destination, Rates & Speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

Ahmed, Imtiaz
Published by VDM Verlag (2016)
ISBN 10: 3639102835 ISBN 13: 9783639102833
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description VDM Verlag, 2016. Paperback. Book Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Bookseller Inventory # ria9783639102833_lsuk

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 42.99
Convert Currency

Add to Basket

Shipping: US$ 5.14
From United Kingdom to U.S.A.
Destination, Rates & Speeds

2.

Ahmed, Imtiaz
ISBN 10: 3639102835 ISBN 13: 9783639102833
New Quantity Available: 1
Seller:
Rating
[?]

Book Description Book Condition: New. Publisher/Verlag: VDM Verlag Dr. Müller | Market Valuation of Firms: An Event Study | The stock and securities market should, ideally, react quickly (efficiently) in response to the public announcement of approval of new drug by the Food and Drug Administration (FDA) and the positive abnormal return may be expected for the sponsoring pharmaceutical company on and around the event date i.e. the day of the public announcement of the new drug approval for marketing. This study has found the mixed outcomes. Briefly, the findings are: (a) Existence of statistically significant positive abnormal returns (AR) for the day following the events. (b) The cumulative abnormal return (CAR) is statistically insignificant for the estimates of the pooled regressions and for some of the individual pharmaceutical companies. (c) No sign of information leakage ahead of the events. (d) Some individual pharmaceutical companies show the existence of statistically significant positive abnormal returns (AR) and the cumulative abnormal return (CAR) for event day and the day after (e.g. Novartis, Abbott, Schering Plough). These findings may play a significant role in the decision making process of mutually exclusive investments in the pharmaceutical products. | Format: Paperback | Language/Sprache: english | 56 pp. Bookseller Inventory # K9783639102833

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 54.93
Convert Currency

Add to Basket

Shipping: US$ 3.51
From Germany to U.S.A.
Destination, Rates & Speeds

3.

Imtiaz Ahmed
Published by VDM Verlag (2008)
ISBN 10: 3639102835 ISBN 13: 9783639102833
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description VDM Verlag, 2008. PAP. Book Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # IQ-9783639102833

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 57.60
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

4.

IMTIAZ AHMED
Published by VDM Verlag Dr. Müller (2008)
ISBN 10: 3639102835 ISBN 13: 9783639102833
New Paperback Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description VDM Verlag Dr. Müller, 2008. Paperback. Book Condition: New. book. Bookseller Inventory # M3639102835

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 66.82
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

5.

Imtiaz Ahmed
Published by VDM Verlag (2008)
ISBN 10: 3639102835 ISBN 13: 9783639102833
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description VDM Verlag, 2008. PAP. Book Condition: New. New Book. Delivered from our UK warehouse in 3 to 5 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # LQ-9783639102833

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 55.32
Convert Currency

Add to Basket

Shipping: US$ 11.92
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

Imtiaz Ahmed
Published by VDM Verlag, Germany (2008)
ISBN 10: 3639102835 ISBN 13: 9783639102833
New Paperback Quantity Available: > 20
Print on Demand
Seller:
The Book Depository EURO
(London, United Kingdom)
Rating
[?]

Book Description VDM Verlag, Germany, 2008. Paperback. Book Condition: New. Language: English . Brand New Book ***** Print on Demand *****.The stock and securities market should, ideally, react quickly (efficiently) in response to the public announcement of approval of new drug by the Food and Drug Administration (FDA) and the positive abnormal return may be expected for the sponsoring pharmaceutical company on and around the event date i.e. the day of the public announcement of the new drug approval for marketing. This study has found the mixed outcomes. Briefly, the findings are: (a) Existence of statistically significant positive abnormal returns (AR) for the day following the events. (b) The cumulative abnormal return (CAR) is statistically insignificant for the estimates of the pooled regressions and for some of the individual pharmaceutical companies. (c) No sign of information leakage ahead of the events. (d) Some individual pharmaceutical companies show the existence of statistically significant positive abnormal returns (AR) and the cumulative abnormal return (CAR) for event day and the day after (e.g. Novartis, Abbott, Schering Plough). These findings may play a significant role in the decision making process of mutually exclusive investments in the pharmaceutical products. Bookseller Inventory # AAV9783639102833

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 69.60
Convert Currency

Add to Basket

Shipping: US$ 3.98
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

IMTIAZ AHMED
Published by VDM Verlag Dez 2008 (2008)
ISBN 10: 3639102835 ISBN 13: 9783639102833
New Taschenbuch Quantity Available: 2
Seller:
Rheinberg-Buch
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description VDM Verlag Dez 2008, 2008. Taschenbuch. Book Condition: Neu. Neuware - The stock and securities market should, ideally, react quickly (efficiently) in response to the public announcement of approval of new drug by the Food and Drug Administration (FDA) and the positive abnormal return may be expected for the sponsoring pharmaceutical company on and around the event date i.e. the day of the public announcement of the new drug approval for marketing. This study has found the mixed outcomes. Briefly, the findings are: (a) Existence of statistically significant positive abnormal returns (AR) for the day following the events. (b) The cumulative abnormal return (CAR) is statistically insignificant for the estimates of the pooled regressions and for some of the individual pharmaceutical companies. (c) No sign of information leakage ahead of the events. (d) Some individual pharmaceutical companies show the existence of statistically significant positive abnormal returns (AR) and the cumulative abnormal return (CAR) for event day and the day after (e.g. Novartis, Abbott, Schering Plough). These findings may play a significant role in the decision making process of mutually exclusive investments in the pharmaceutical products. 56 pp. Deutsch. Bookseller Inventory # 9783639102833

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 59.24
Convert Currency

Add to Basket

Shipping: US$ 20.11
From Germany to U.S.A.
Destination, Rates & Speeds

8.

IMTIAZ AHMED
Published by VDM Verlag Dez 2008 (2008)
ISBN 10: 3639102835 ISBN 13: 9783639102833
New Taschenbuch Quantity Available: 2
Seller:
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description VDM Verlag Dez 2008, 2008. Taschenbuch. Book Condition: Neu. Neuware - The stock and securities market should, ideally, react quickly (efficiently) in response to the public announcement of approval of new drug by the Food and Drug Administration (FDA) and the positive abnormal return may be expected for the sponsoring pharmaceutical company on and around the event date i.e. the day of the public announcement of the new drug approval for marketing. This study has found the mixed outcomes. Briefly, the findings are: (a) Existence of statistically significant positive abnormal returns (AR) for the day following the events. (b) The cumulative abnormal return (CAR) is statistically insignificant for the estimates of the pooled regressions and for some of the individual pharmaceutical companies. (c) No sign of information leakage ahead of the events. (d) Some individual pharmaceutical companies show the existence of statistically significant positive abnormal returns (AR) and the cumulative abnormal return (CAR) for event day and the day after (e.g. Novartis, Abbott, Schering Plough). These findings may play a significant role in the decision making process of mutually exclusive investments in the pharmaceutical products. 56 pp. Deutsch. Bookseller Inventory # 9783639102833

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 59.24
Convert Currency

Add to Basket

Shipping: US$ 20.11
From Germany to U.S.A.
Destination, Rates & Speeds

9.

Imtiaz Ahmed
Published by VDM Verlag
ISBN 10: 3639102835 ISBN 13: 9783639102833
New Paperback Quantity Available: > 20
Seller:
BuySomeBooks
(Las Vegas, NV, U.S.A.)
Rating
[?]

Book Description VDM Verlag. Paperback. Book Condition: New. Paperback. 56 pages. Dimensions: 8.7in. x 5.9in. x 0.1in.The stock and securities market should, ideally, react quickly (efficiently) in response to the public announcement of approval of new drug by the Food and Drug Administration (FDA) and the positive abnormal return may be expected for the sponsoring pharmaceutical company on and around the event date i. e. the day of the public announcement of the new drug approval for marketing. This study has found the mixed outcomes. Briefly, the findings are: (a) Existence of statistically significant positive abnormal returns (AR) for the day following the events. (b) The cumulative abnormal return (CAR) is statistically insignificant for the estimates of the pooled regressions and for some of the individual pharmaceutical companies. (c) No sign of information leakage ahead of the events. (d) Some individual pharmaceutical companies show the existence of statistically significant positive abnormal returns (AR) and the cumulative abnormal return (CAR) for event day and the day after (e. g. Novartis, Abbott, Schering Plough). These findings may play a significant role in the decision making process of mutually exclusive investments in the pharmaceutical products. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Paperback. Bookseller Inventory # 9783639102833

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 83.67
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

10.

IMTIAZ AHMED
Published by VDM Verlag Dez 2008 (2008)
ISBN 10: 3639102835 ISBN 13: 9783639102833
New Taschenbuch Quantity Available: 1
Print on Demand
Seller:
AHA-BUCH GmbH
(Einbeck, Germany)
Rating
[?]

Book Description VDM Verlag Dez 2008, 2008. Taschenbuch. Book Condition: Neu. This item is printed on demand - Print on Demand Neuware - The stock and securities market should, ideally, 56 pp. Deutsch. Bookseller Inventory # 9783639102833

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 59.24
Convert Currency

Add to Basket

Shipping: US$ 34.63
From Germany to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book